SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-21-001172
Filing Date
2021-02-11
Accepted
2021-02-11 08:54:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 XERIS PHARMACEUTICALS, INC. p21-0476sc13ga.htm SC 13G/A 60814
  Complete submission text file 0000902664-21-001172.txt   62324
Mailing Address 250 WEST 55TH STREET, FLOOR 29 NEW YORK NY 10019
Business Address 250 WEST 55TH STREET, FLOOR 29 NEW YORK NY 10019 (212) 872-1054
SOROS FUND MANAGEMENT LLC (Filed by) CIK: 0001029160 (see all company filings)

IRS No.: 133914976 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Subject) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90534 | Film No.: 21616994
SIC: 2834 Pharmaceutical Preparations